Bronchipret oral solution 50ml №1

Name:
Bronchipret. Release form Drops. INN ivy leaf extract + common thyme herb extract. FTGOExpectorant of plant origin. Composition 1 ml (equivalent to 1 g) of solution contains: 0.5 ml of thyme herb liquid extract (1 : 2-2.5) (extractant: ammonia solution 10% (m/m), glycerol 85% (m/m), ethanol 90% (v/v), purified water (1:20:70:109)); 0.03 ml liquid extract from ivy leaves (1:1) extractant – ethanol 70% (v/v). Auxiliary ingredients: ethanol 96% (v/v), purified water, hydroxypropyl betadex, sodium saccharin dihydrate, citric acid monohydrate. Contains 24% (v/v) ethanol.
Description:
Brownish, clear or turbid liquid with thyme aroma. A slight precipitation may occur. Pharmacotherapeutic group Expectorants in combination Pharmacological properties The results of experimental studies in vitro and animal studies with preparations of thyme and thyme oil or its main component thymol showed a weak expectorant and antispasmodic effect. Pharmacological studies in humans using individual extracts, as well as with a fixed combination, have not been conducted. Indications for use For the relief of symptoms in acute inflammatory diseases of the respiratory tract, accompanied by cough and the formation of viscous sputum. Contraindications Children’s age up to 6 years. Bronchipret solution should not be taken in cases of known hypersensitivity to common ivy, thyme or other plants of the Lamiaceae family, in case of a known allergic reaction to birch pollen, mugwort, celery, or to any other component of the drug. Special warnings and precautions Not prescribed for children under 6 years of age due to the lack of a sufficient number of clinical studies of the use. If symptoms persist for more than 7 days, or shortness of breath, fever or hemoptysis develops when using the drug, you should immediately consult a doctor. Due to the content of ethyl alcohol in children aged 6 to 12 years, the interval between doses should be at least 4 hours. If during the use of the drug the symptoms worsen, you should consult your doctor. The drug contains 24% (v/v) ethanol, i.e. up to 0.49 g per single dose of 2.6 ml. Due to the content of ethyl alcohol, the drug should not be taken by patients suffering from alcoholism. The ethanol content should be taken into account when prescribing to high-risk patients such as those with liver disease or epilepsy. A single dose of Bronchipret solution does not contain countable bread units (XE). Take with caution in patients with gastritis or peptic ulcer disease. Bronchipret, solution does not contain gluten. Interaction with other medicinal products Simultaneous use with antitussive drugs is not recommended. Application during pregnancy and lactation It is not recommended to take the drug during pregnancy and lactation. Effects on the ability to drive a car or use machines The drug contains ethyl alcohol! During the period of treatment, care must be taken when driving vehicles and engaging in other potentially hazardous activities that require concentration and speed of psychomotor reactions. Dosage and administration Apply inside. Adults and children over 12 years old: 2.6 ml 3 times a day Children aged 6 to 11 years: 1.3 ml 3 times a day Take the solution with a measuring cup and, if necessary, take with some liquid (for example, with a glass of water). Shake the bottle before use! The duration of treatment depends on the severity of the disease. If symptoms persist for more than 7 days, or if shortness of breath, fever, or hemoptysis develop, a physician should be consulted. Due to the content of ethyl alcohol in children aged 6 to 12 years, the interval between doses should be at least 4 hours. Side effects When taking Bronchipret solution, like any other drug, side reactions may occur. When assessing side effects, the following data are based on the frequency of their occurrence: Very often: ≥1/10 Often: ≥1/100, but <1/10 Uncommon: ≥1/1000, but <1/100 Rare: ≥1/10 10,000 but <1/1000 Very rare: <1/10,000 Not known: frequency cannot be determined from available data Gastrointestinal disorders (cramps, nausea, vomiting) have been reported infrequently. In very rare cases, allergic reactions are possible, such as shortness of breath, skin rash, urticaria, swelling of the face, lips and / or larynx. In case of the first signs of side effects, stop using the drug and consult a doctor. At the first sign of an allergic reaction, Bronchipret solution should be discontinued immediately. Reporting Suspected Adverse Reactions It is important to report suspected adverse reactions after drug registration. This allows you to control the further benefit / risk ratio of the drug. Please report any suspected adverse reactions through the national reporting system (UE Center for Expertise and Testing in Healthcare of the Ministry of Health of the Republic of Belarus, rceth.by). Overdose When taking the drug in doses significantly higher than therapeutic, gastrointestinal disorders, vomiting, and diarrhea are possible. In case of overdose, a doctor's consultation is necessary. Shelf life 24 months, after opening - 6 months. The expiration date is indicated on the packaging. Do not use after the expiration date. Storage conditions Store in a place protected from light and moisture, at a temperature not exceeding 25°C. Keep out of the reach of children! Release form Dark glass bottles with a filling device of 50 ml and 100 ml and a measuring cup, together with instructions for medical use, are placed in a folding cardboard box. Holiday conditions Without a doctor's prescription. Buy Bronchipret oral solution 50ml №1 Price for Bronchipret oral solution 50ml №1 Instructions for use for Bronchipret oral solution 50ml №1